See more : Sixth Wave Innovations Inc. (SIXW.CN) Income Statement Analysis – Financial Results
Complete financial analysis of Helius Medical Technologies, Inc. (HSM.TO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Helius Medical Technologies, Inc., a leading company in the Medical – Devices industry within the Healthcare sector.
- Daeduck Co.,Ltd. (008060.KS) Income Statement Analysis – Financial Results
- Element Nutritional Sciences Inc. (ELNSF) Income Statement Analysis – Financial Results
- Integrated Design & Engineering Holdings Co.,Ltd. (9161.T) Income Statement Analysis – Financial Results
- First Commerce Bank (CMRB) Income Statement Analysis – Financial Results
- Unum Group (0LJN.L) Income Statement Analysis – Financial Results
Helius Medical Technologies, Inc. (HSM.TO)
About Helius Medical Technologies, Inc.
Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-invasive technologies for the treatment of symptoms caused by neurological disease or trauma. The company's product is Portable Neuromodulation Stimulator (PoNS), a medical device in Canada for the treatment of chronic balance deficit due to mild-to-moderate traumatic brain injury. Its PoNS device treats neurostimulation of cranial nerves via the tongue to restore lost function. The company is headquartered in Newtown, Pennsylvania.
| Metric | 2020 | 2019 | 2018 | 2017 | 2014 | 2013 | 2012 |
|---|---|---|---|---|---|---|---|
| Revenue | 661.00K | 1.50M | 478.00K | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 388.00K | 846.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 273.00K | 650.00K | 478.00K | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit Ratio | 41.30% | 43.45% | 100.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Research & Development | 4.58M | 8.06M | 9.94M | 14.39M | 3.83M | 171.78K | 4.25M |
| General & Administrative | 0.00 | 0.00 | 17.21M | 8.47M | 4.26M | 895.50K | 4.27M |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 774.40K | 0.00 | 0.00 |
| SG&A | 0.00 | 0.00 | 17.21M | 8.47M | 5.04M | 895.50K | 4.27M |
| Other Expenses | 10.08M | 16.59M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 14.66M | 24.65M | 27.15M | 22.85M | 8.86M | 1.07M | 8.52M |
| Cost & Expenses | 15.05M | 25.49M | 27.15M | 22.85M | 8.86M | 1.07M | 8.52M |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 176.49K | 0.00 | 0.00 |
| Depreciation & Amortization | 482.00K | 191.00K | 59.00K | 17.00K | 146.62K | 0.00 | 0.00 |
| EBITDA | -13.65M | -9.59M | -28.56M | -28.01M | -8.72M | -1.07M | -8.52M |
| EBITDA Ratio | -2,064.75% | -641.04% | -5,975.73% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Income | -14.39M | -24.00M | -26.68M | -22.85M | -8.86M | -1.07M | -8.52M |
| Operating Income Ratio | -2,176.40% | -1,604.01% | -5,580.54% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | 256.00K | 14.22M | -1.95M | -5.17M | -29.87K | 0.00 | 0.00 |
| Income Before Tax | -14.13M | -9.78M | -28.62M | -28.02M | -8.89M | -1.07M | -8.52M |
| Income Before Tax Ratio | -2,137.67% | -653.81% | -5,988.08% | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 256.00K | 14.22M | -1.95M | -5.17M | 0.00 | 0.00 | -8.52M |
| Net Income | -14.13M | -9.78M | -28.62M | -28.02M | -8.89M | -1.07M | 0.00 |
| Net Income Ratio | -2,137.67% | -653.81% | -5,988.08% | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | -11.80 | -12.99 | -43.97 | -52.64 | -27.29 | -2.96 | 0.00 |
| EPS Diluted | -11.80 | -12.99 | -43.97 | -52.64 | -27.29 | -2.96 | 0.00 |
| Weighted Avg Shares Out | 1.20M | 752.92K | 651.02K | 532.36K | 325.99K | 360.59K | 6.41M |
| Weighted Avg Shares Out (Dil) | 1.20M | 752.92K | 651.02K | 532.36K | 325.99K | 360.59K | 6.41M |
Source: https://incomestatements.info
Category: Stock Reports